Pure Global AI
NCT06009471Recruiting

A Multicenter Clinical Study of rTMS for Parkinson's Disease

Affiliated Hospital of Nantong UniversityClinicalTrials.govother
Verified
Study focus
Disease/Condition
Parkinson's Disease
Drug/Device/Intervention
Routine treatment in Neurology
Study type
Interventional
Intervention type
other
Sponsor & location
Primary sponsor
Affiliated Hospital of Nantong University
Location
Nantong, China
Timeline & enrollment
Phase
N/A
Start date
Jul 01, 2023
End date
Aug 01, 2025
Enrollment
200 participants
Primary outcome

Unified Parkinson's disease rating Scale （UPDRS）,Montreal Cognitive Assessment Scale (MoCA),King's Parkinson's Pain Assessment (KPPS),PD Sleep Scale (PDSS),Activities of daily living Assessment - Barthel

Summary

Through rTMS, motor dysfunction and non-motor dysfunction of PD patients can be improved,
 working and living ability and quality of life of patients can be improved, and social burden
 and family burden can be reduced.

ICD-10 classifications
Parkinson diseaseParkinsonism in diseases classified elsewhereDementia in Parkinson diseaseSecondary parkinsonismPostencephalitic parkinsonism
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06009471
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06009471 through Pure Global AI's free database. This phase not specified trial is sponsored by Affiliated Hospital of Nantong University and is currently Recruiting. The study focuses on Parkinson's Disease. Target enrollment is 200 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.